ELBW and ELGAN outcomes in developing nations-Systematic review and meta-analysis.

<h4>Context</h4>Morbidity and mortality amongst extremely low birth weight (ELBW) and extremely low gestational age neonates (ELGANs) in developing nations has not been well studied.<h4>Objectives</h4>Evaluate survival until discharge, short- and long-term morbidities of ELBW...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Viraraghavan Vadakkencherry Ramaswamy, Thangaraj Abiramalatha, Tapas Bandyopadhyay, Nasreen Banu Shaik, Prathik Bandiya, Debasish Nanda, Abdul Kareem Pullattayil S, Srinivas Murki, Charles Christoph Roehr
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/e3df4eac6f56464e91a9b8fefe1b0b19
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e3df4eac6f56464e91a9b8fefe1b0b19
record_format	dspace
spelling	oai:doaj.org-article:e3df4eac6f56464e91a9b8fefe1b0b192021-12-02T20:18:36ZELBW and ELGAN outcomes in developing nations-Systematic review and meta-analysis.1932-620310.1371/journal.pone.0255352https://doaj.org/article/e3df4eac6f56464e91a9b8fefe1b0b192021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0255352https://doaj.org/toc/1932-6203<h4>Context</h4>Morbidity and mortality amongst extremely low birth weight (ELBW) and extremely low gestational age neonates (ELGANs) in developing nations has not been well studied.<h4>Objectives</h4>Evaluate survival until discharge, short- and long-term morbidities of ELBW and ELGANs in LMICs.<h4>Data sources</h4>CENTRAL, EMBASE, MEDLINE and Web of Science.<h4>Study selection</h4>Prospective and retrospective observational studies were included.<h4>Data extraction and synthesis</h4>Four authors extracted data independently. Random-effects meta-analysis of proportions was used to synthesize data, modified QUIPS scale to evaluate quality of studies and GRADE approach to ascertain the certainty of evidence (CoE).<h4>Results</h4>192 studies enrolling 22,278 ELBW and 18,338 ELGANs were included. Survival was 34% (95% CI: 31% - 37%) (CoE-low) for ELBW and 39% (34% - 44%) (CoE-moderate) for ELGANs. For ELBW neonates, the survival for low-income (LI), lower middle-income (LMI) and upper middle income (UMI) countries was 18% (11% - 28%), 28% (21% - 35%) and 39% (36% - 42%), respectively. For ELGANs, it was 13% (8% - 20%) for LI, 28% (21% - 36%) for LMI and 48% (42% - 53%) for UMI countries. There was no difference in survival between two epochs: 2000-2009 and 2010-2020. Except for necrotising enterocolitis [ELBW and ELGANs-8% (7% - 10%)] and periventricular leukomalacia [ELBW-7% (4% - 11%); ELGANs-6% (5%-7%)], rates of all other morbidities were higher compared to developed nations. Rates of neurodevelopmental impairment was 17% (7% - 34%) in ELBW neonates and 29% (23% - 37%) in ELGANs.<h4>Limitations</h4>CoE was very low to low for all secondary outcomes.<h4>Conclusions</h4>Mortality and morbidity amongst ELBW and ELGANs is still a significant burden in LMICs. CoE was very low to low for all the secondary outcomes, emphasizing the need for high quality prospective cohort studies.<h4>Trial registration</h4>PROSPERO (CRD42020222873).Viraraghavan Vadakkencherry RamaswamyThangaraj AbiramalathaTapas BandyopadhyayNasreen Banu ShaikPrathik BandiyaDebasish NandaAbdul Kareem Pullattayil SSrinivas MurkiCharles Christoph RoehrPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 8, p e0255352 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Viraraghavan Vadakkencherry Ramaswamy Thangaraj Abiramalatha Tapas Bandyopadhyay Nasreen Banu Shaik Prathik Bandiya Debasish Nanda Abdul Kareem Pullattayil S Srinivas Murki Charles Christoph Roehr ELBW and ELGAN outcomes in developing nations-Systematic review and meta-analysis.
description	<h4>Context</h4>Morbidity and mortality amongst extremely low birth weight (ELBW) and extremely low gestational age neonates (ELGANs) in developing nations has not been well studied.<h4>Objectives</h4>Evaluate survival until discharge, short- and long-term morbidities of ELBW and ELGANs in LMICs.<h4>Data sources</h4>CENTRAL, EMBASE, MEDLINE and Web of Science.<h4>Study selection</h4>Prospective and retrospective observational studies were included.<h4>Data extraction and synthesis</h4>Four authors extracted data independently. Random-effects meta-analysis of proportions was used to synthesize data, modified QUIPS scale to evaluate quality of studies and GRADE approach to ascertain the certainty of evidence (CoE).<h4>Results</h4>192 studies enrolling 22,278 ELBW and 18,338 ELGANs were included. Survival was 34% (95% CI: 31% - 37%) (CoE-low) for ELBW and 39% (34% - 44%) (CoE-moderate) for ELGANs. For ELBW neonates, the survival for low-income (LI), lower middle-income (LMI) and upper middle income (UMI) countries was 18% (11% - 28%), 28% (21% - 35%) and 39% (36% - 42%), respectively. For ELGANs, it was 13% (8% - 20%) for LI, 28% (21% - 36%) for LMI and 48% (42% - 53%) for UMI countries. There was no difference in survival between two epochs: 2000-2009 and 2010-2020. Except for necrotising enterocolitis [ELBW and ELGANs-8% (7% - 10%)] and periventricular leukomalacia [ELBW-7% (4% - 11%); ELGANs-6% (5%-7%)], rates of all other morbidities were higher compared to developed nations. Rates of neurodevelopmental impairment was 17% (7% - 34%) in ELBW neonates and 29% (23% - 37%) in ELGANs.<h4>Limitations</h4>CoE was very low to low for all secondary outcomes.<h4>Conclusions</h4>Mortality and morbidity amongst ELBW and ELGANs is still a significant burden in LMICs. CoE was very low to low for all the secondary outcomes, emphasizing the need for high quality prospective cohort studies.<h4>Trial registration</h4>PROSPERO (CRD42020222873).
format	article
author	Viraraghavan Vadakkencherry Ramaswamy Thangaraj Abiramalatha Tapas Bandyopadhyay Nasreen Banu Shaik Prathik Bandiya Debasish Nanda Abdul Kareem Pullattayil S Srinivas Murki Charles Christoph Roehr
author_facet	Viraraghavan Vadakkencherry Ramaswamy Thangaraj Abiramalatha Tapas Bandyopadhyay Nasreen Banu Shaik Prathik Bandiya Debasish Nanda Abdul Kareem Pullattayil S Srinivas Murki Charles Christoph Roehr
author_sort	Viraraghavan Vadakkencherry Ramaswamy
title	ELBW and ELGAN outcomes in developing nations-Systematic review and meta-analysis.
title_short	ELBW and ELGAN outcomes in developing nations-Systematic review and meta-analysis.
title_full	ELBW and ELGAN outcomes in developing nations-Systematic review and meta-analysis.
title_fullStr	ELBW and ELGAN outcomes in developing nations-Systematic review and meta-analysis.
title_full_unstemmed	ELBW and ELGAN outcomes in developing nations-Systematic review and meta-analysis.
title_sort	elbw and elgan outcomes in developing nations-systematic review and meta-analysis.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/e3df4eac6f56464e91a9b8fefe1b0b19
work_keys_str_mv	AT viraraghavanvadakkencherryramaswamy elbwandelganoutcomesindevelopingnationssystematicreviewandmetaanalysis AT thangarajabiramalatha elbwandelganoutcomesindevelopingnationssystematicreviewandmetaanalysis AT tapasbandyopadhyay elbwandelganoutcomesindevelopingnationssystematicreviewandmetaanalysis AT nasreenbanushaik elbwandelganoutcomesindevelopingnationssystematicreviewandmetaanalysis AT prathikbandiya elbwandelganoutcomesindevelopingnationssystematicreviewandmetaanalysis AT debasishnanda elbwandelganoutcomesindevelopingnationssystematicreviewandmetaanalysis AT abdulkareempullattayils elbwandelganoutcomesindevelopingnationssystematicreviewandmetaanalysis AT srinivasmurki elbwandelganoutcomesindevelopingnationssystematicreviewandmetaanalysis AT charleschristophroehr elbwandelganoutcomesindevelopingnationssystematicreviewandmetaanalysis
_version_	1718374318407155712

ELBW and ELGAN outcomes in developing nations-Systematic review and meta-analysis.

Ejemplares similares